<sentences><s id="0">Intronic variants in <e id="UNIPROT:Q9Y6L6:T116:PRGE">SLCO1B1</e> related to <e id="UNIPROT:Q05639:T116:PRGE">statin</e>-induced <e id="UMLS:C0026848:T047:DISO">myopathy</e> are associated with the low-density lipoprotein cholesterol response to statins in Chinese patients with <e id="UMLS:C0020473:T047:DISO">hyperlipidaemia</e>.</s>
<s id="1">Whole-genome studies have identified several intronic single nucleotide polymorphisms (SNPs) in <e id="UNIPROT:Q9Y6L6:T116:PRGE">SLCO1B1</e> associated with simvastatin-induced <e id="UMLS:C0026848:T047:DISO">myopathy</e>.</s> <s id="2">The present study determined the effect of an intronic SNP rs4149081 in SLCO1B1 on the lipid-lowering effects of simvastatin and rosuvastatin in Chinese patients with <e id="UMLS:C0020443:T047:DISO">hypercholesterolaemia</e>.</s> <s id="3">Lipid profiles were determined off treatment and after at least 4 weeks of treatment with each of the statins at daily doses of rosuvastatin 10 mg and simvastatin 40 mg.</s> <s id="4">In 247 patients with good adherence, the rs4149081 G&gt;A polymorphism was significantly associated with a 4.6 and 4.0% greater low-density lipoprotein cholesterol (LDL-C) reduction compared with those with wild-type alleles in response to rosuvastatin and simvastatin, respectively (P&lt;0.05 for both).</s> <s id="5">The 388A&gt;G and 521T&gt;C polymorphisms were not associated with the LDL-C response to either statin.</s> <s id="6">The intronic SNP rs4149081 in SLCO1B1 was associated with the LDL-C response to statins in Chinese patients and this association was independent of the 521T&gt;C polymorphism.</s></sentences>